Plasma proteins other than immunoglobulins (None commonly used; plasma proteins may be collectively abbreviated as "PPs," but not standardized specifically for non-immunoglobulin plasma proteins.)
Target
None commonly used; plasma proteins may be collectively abbreviated as "PPs," but not standardized specifically for non-immunoglobulin plasma proteins.
Molecular classification
Transport protein (e.g., albumin, transferrin), Acute phase protein (e.g., C-reactive protein, serum amyloid A), Coagulation factor (e.g., factor VIII, fibrinogen), Complement protein (e.g., C3, C4), Protease inhibitor (e.g., alpha-1 antitrypsin, antithrombin), Enzyme (e.g., plasminogen), Oncofetal protein (e.g., alpha-fetoprotein), Other (soluble receptors, shed membrane proteins)
01
Overview
Plasma proteins other than immunoglobulins are a diverse group of soluble proteins present in blood plasma, responsible for vital physiological functions including transport of substances, maintenance of oncotic pressure, blood coagulation, immune defense, inflammation regulation, and tissue repair. This group comprises albumin, acute phase proteins, coagulation factors, complement proteins, transporters, protease inhibitors, oncofetal proteins, and other soluble shed proteins. Most are synthesized in the liver (with some exceptions), and their broad involvement in disease and medical therapy underscores their importance as both diagnostic biomarkers and therapeutic targets in hematology, immunology, cardiovascular, oncologic, hepatic, and genetic conditions. The category is not a specific molecular target but a collective term for multiple clinically important plasma soluble proteins.
Replacement therapy: restoring deficient plasma proteins
Inhibition of protein activity: e.g., direct inhibition of complement, clotting cascade
Modulation of inflammatory response: dampening acute-phase protein synthesis, cytokine signaling
Protein binding: transport/drug displacement effects
Immune modulation
03
Biological functions
Transport of hormones, drugs, and metabolites (albumin, transferrin)Blood coagulation and hemostasis (clotting factors, fibrinogen)Immune response modulation (complement proteins, acute phase proteins)Inflammation regulation (acute phase proteins)Protease inhibition (alpha-1 antitrypsin, antithrombin)Tissue repair, cell signaling (thrombospondin-2, soluble transferrin receptor)Other (oncoprotection, fetal development)
Go deeper on Plasma proteins other than immunoglobulins (None commonly used; plasma proteins may be collectively abbreviated as "PPs," but not standardized specifically for non-immunoglobulin plasma proteins.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Plasma proteins other than immunoglobulins (None commonly used; plasma proteins may be collectively abbreviated as "PPs," but not standardized specifically for non-immunoglobulin plasma proteins.).